Orbimed Advisors - AVALANCHE BIOTECHNOLOGIES IN ownership

Back to all holdings Add to watchlist

AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.

Links
Filings
External links
Quarter-by-quarter ownership
Orbimed Advisors ownership history of AVALANCHE BIOTECHNOLOGIES IN
ValueSharesWeighting
Q2 2015$4,060,000
-64.7%
250,000
-11.9%
0.03%
-69.4%
Q1 2015$11,504,000–283,900–0.10%–
 Download
Other shareholders

There were no reported owners of AVALANCHE BIOTECHNOLOGIES IN in Q3 2023.

NameSharesValueWeighting ↓
View complete list of AVALANCHE BIOTECHNOLOGIES IN shareholders